Company newsroom

Cumberland Pharmaceuticals Inc.

NASDAQ:CPIX

2 releases

Cumberland Pharmaceuticals Inc.Oct 23, 2026

Cumberland Pharmaceuticals Announces ASSIST-SSc Trial Top-Line Results

Ifetroban was well tolerated in patients with systemic sclerosis NASHVILLE, Tenn., Oct. 23, 2026 — Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), an…

Cumberland Pharmaceuticals Inc.Oct 23, 2026

CUMBERLAND PHARMACEUTICALS PROVIDES UPDATED WEBCAST REGISTRATION LINK FOR IFETROBAN DMD PROGRAM CALL

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), an innovation-driven biopharmaceutical company advancing new therapies that address significant unmet…